3
Announcements
Trials
Browse
Landscape
Status
Completed
82
Terminated
11
Unknown
7
Active not recruiting
7
Withdrawn
6
Recruiting
5
Sponsor Class
OTHER
64
INDUSTRY
21
OTHER_GOV
1
NIH
1
Sponsor
Interventions
Specimen Handling
7
Magnetic Resonance Spectroscopy
7
Radiotherapy
5
Biopsy
4
Radiation
3
High-Energy Shock Waves
3
Cyclophosphamide
3
venetoclax
2
X-Rays
2
Vincristine
2
Spinal Puncture
2
Sentinel Lymph Node Biopsy
2
Radiosurgery
2
Paclitaxel
2
Daunorubicin
2
Cytarabine
2
Azacitidine
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
sulforaphane
1
sacituzumab govitecan
1
revumenib
1
prednylidene
1
pertuzumab
1
pembrolizumab
1
pegaspargase
1
nelarabine
1
merphos
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Not yet recruiting
×
NETWORK
×
Gemcitabine
×
Clear all
No trials found.